Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Eric H Yang"'
Autor:
Ahmed Sayed, Malak Munir, Eric H Yang, Daniel Addison, Sarah Khan, Jiwon Kim, Syed Mahmood, Narendranath Epperla, Alexa Meara, Sanam M Ghazi, Mussammat Ferdousi, Satyam Krishan, Adnan Shaaban, Alma Habib, Onaopepo Kola-Kehinde, Patrick Ruz, Sneha Sharma, Stephanie Feldman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background Bispecific T-cell engagers (BTEs) are novel agents used to treat hematological malignancies. Early trials were underpowered to define cardiovascular adverse events (CVAE) and no large-scale studies systematically examined the CVAEs associa
Externí odkaz:
https://doaj.org/article/4daf6a6fa2be4e8dbd01f020034d0b6a
Autor:
Pradyumna Agasthi, Kantha Ratnam Kolla, Charan Yerasi, Sibghat Tullah, Venkata Siva Pulivarthi, Boshra Louka, Reza Arsanjani, Eric H Yang, Farouk Mookadam, F David Fortuin
Publikováno v:
SAGE Open Medicine, Vol 7 (2019)
Background: We performed a meta-analysis to evaluate the benefit of patent foramen ovale closure in stroke prevention. Methods: We searched Medline/PubMed, EMBASE, Web of Science and Cochrane central database for randomized control trials assessing t
Externí odkaz:
https://doaj.org/article/68dd205aa66f4a2786a61dc37e8fdf61
Publikováno v:
PLoS ONE, Vol 4, Iss 7, p e5992 (2009)
One of the challenges in exploiting high throughput measurement techniques such as microarrays is the conversion of the vast amounts of data obtained into relevant knowledge. Of particular importance is the identification of the intrinsic response of
Externí odkaz:
https://doaj.org/article/6cd491aa974f47aaa230250c71e8b529
Publikováno v:
Cardio-Oncology, Vol 8, Iss 1, Pp 1-15 (2022)
Abstract Background Malignancy is known to be a major cause of death in adult congenital heart disease (ACHD). However, data regarding cardiovascular and cancer-related outcomes in ACHD are lacking. Methods We conducted a retrospective single-center
Externí odkaz:
https://doaj.org/article/81e484b3423a48d6930287e3b74bc1c7
Autor:
René R. Sevag Packard, Eric H. Yang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
Externí odkaz:
https://doaj.org/article/6ef13afd0c5a4db3ac1f4e7a85370f42
Autor:
Muhammad Mustafa Alhussein, MD, Abir Mokbel, MD, MSc, Tammy Cosman, RN(EC), PhD, Nazanin Aghel, MD, Eric H. Yang, MD, Som D. Mukherjee, MD, Susan Dent, MD, Peter M. Ellis, MBBS, MMed, PhD, Sukhbinder Dhesy-Thind, MD, MSc, Darryl P. Leong, MBBS, MPH, M. Biostat, PhD
Publikováno v:
CJC Open, Vol 3, Iss 11, Pp 1372-1382 (2021)
Background: Human epidermal growth factor receptor 2 (HER2) overexpressing malignancies, including breast and gastro-esophageal, are associated with a poor prognosis. The cardiotoxicity of trastuzumab, a HER2-targeting monoclonal antibody, is well es
Externí odkaz:
https://doaj.org/article/19ebfb6c8fb04bf8886b70411a949d57
Autor:
Ashley F. Stein‐Merlob, Jeffrey J. Hsu, Bradley Colton, Christopher J. Berg, Allison Ferreira, Megan M. Price, Zev Wainberg, Arnold S. Baas, Mario C. Deng, Rushi V. Parikh, Eric H. Yang
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4301-4306 (2021)
Abstract Immune checkpoint inhibitor (ICI)‐associated myocarditis is a rare, potentially life‐threatening complication of immunotherapy. We report a case of a 60‐year‐old female with a history of colorectal cancer treated with nivolumab immun
Externí odkaz:
https://doaj.org/article/e267b508b25d4eb88f9662f24c2173a2
Autor:
Sara Alsterlind Hurvitz, Nicholas P. McAndrew, Aditya Bardia, Michael F. Press, Mark Pegram, John P. Crown, Peter A. Fasching, Bent Ejlertsen, Eric H. Yang, John A. Glaspy, Dennis J. Slamon
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-25 (2021)
Abstract It has been over three decades since anthracyclines took their place as the standard chemotherapy backbone for breast cancer in the curative setting. Though the efficacy of anthracycline chemotherapy is not debatable, potentially life-threat
Externí odkaz:
https://doaj.org/article/aad7894979b94db08a790483d6338a18
Autor:
Marta Fonseca, Evaline Cheng, Duc Do, Shouvik Haldar, Shelby Kutty, Eric H. Yang, Arjun K. Ghosh, Avirup Guha
Publikováno v:
South Asian Journal of Cancer, Vol 10, Iss 03, Pp 195-210 (2021)
The relationship between bradyarrhythmias and cancer therapies has not been well described but is increasingly recognized. There have been extensive advances in oncological pharmacotherapy, with several new classes of drugs available including target
Externí odkaz:
https://doaj.org/article/eae8c646f407421fac652ec1e244e47d
Autor:
Ayesha Safdar, Talha Ahmed, Victor Y. Liu, Antoine Addoumieh, Ali M. Agha, Dana E. Giza, Dinu V. Balanescu, Teodora Donisan, Tariq Dayah, Juan C. Lopez-Mattei, Peter Y. Kim, Saamir Hassan, Kaveh Karimzad, Nicolas Palaskas, January Y. Tsai, Gloria D. Iliescu, Eric H. Yang, Joerg Herrmann, Konstantinos Marmagkiolis, Paolo Angelini, Cezar A. Iliescu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundTakotsubo syndrome (TTS) occurs more frequently in cancer patients than in the general population, but the effect of specific TTS triggers on outcomes in cancer patients is not well studied.ObjectivesThe study sought to determine whether tr
Externí odkaz:
https://doaj.org/article/90909e98ce55469b9da6ce079f990e6e